Extracellular matrix cancer vaccine adjuvant

Details for Australian Patent Application No. 2007309193 (hide)

Owner UNIVERSITY OF NOTRE DAME

Inventors Wolter, William R.; Suckow, Mark A.

Agent Griffith Hack

Pub. Number AU-A-2007309193

PCT Pub. Number WO2008/051852

Priority 11/583,771 20.10.06 US

Filing date 19 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/33 (1970.01) Peptides having more than 20 amino acids

C07K 14/415 (2006.01) Peptides having more than 20 amino acids - from plants

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051852 Priority application(s): WO2008/051852

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309195-Cathepsin proteases inhibitors

2007309183-Methods and systems for accessing remote user files associated with local resources